Trial intelligence / Profile preview

Pre-hospital antiemetic trial for nausea and vomiting

ACTRN12608000576325Phase 4Not yet recruiting

Sponsor
St John Ambulance
Start
Nov 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in Nausea and Vomiting comparing Ondansetron IM, Midazolam IM and Metoclopramide IM control (3 arms). Primary endpoint: Reduction in nausea and vomiting. Planned start Nov 2008; status: not yet recruiting.

02

Drugs

ondansetronmidazolammetoclopramide
03

Conditions

Nausea and Vomiting

Beyond the preview

Go deeper on ACTRN12608000576325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12608000576325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call